A COMPARATIVE EVALUATION OF THE HEALTH ECONOMIC OUTCOMES OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS WITH CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Mitri, G. [1 ]
Wittbrodt, E. T. [1 ]
Turpin, R. S. [1 ]
Costa, L. A. [2 ]
Schulman, K. [2 ]
机构：
[1] Takeda Pharmaceut Inc, Med Affairs, Deerfield, IL USA
[2] Outcomes Res Solut Inc, Shrewsbury, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1625
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0174
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [41] CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
    White, William B.
    Chohan, Saima
    Dabholkar, Aruna
    Hunt, Barbara
    Jackson, Robert
    AMERICAN HEART JOURNAL, 2012, 164 (01) : 14 - 20
  • [42] Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression
    Park, Seokwoo
    Lee, Jung Pyo
    Kim, Dong Ki
    Kim, Yon Su
    Lim, Chun Soo
    PLOS ONE, 2022, 17 (02):
  • [43] FEBUXOSTAT MAY BE USEFULLY UTILIZED FOR ALLOPURINOL-REFRACTORY HYPERURICEMIA IN GOUT TREATMENT OF DIALYSIS PATIENTS OR THOSE IN STAGE 4 CHRONIC KIDNEY DISEASE ( CKD)
    Son, C. -N.
    Jeong, H. -J.
    Kim, J. -M.
    Kim, H. -S.
    Kim, S. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 538 - 538
  • [44] A Meta-Analysis for Comparing the Effects of Febuxostat and Allopurinol on Kidney Function in Hyperuricemia Patients Complicated with Chronic Kidney Disease
    Wang, Yu
    Chen, Kai
    Zhou, Su-ya
    Qiao, Zi-xuan
    Bao, Xiao-rong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [45] Clinical and Health Care Use Characteristics of Patients Newly Prescribed Allopurinol, Febuxostat and Colchicine for Gout
    Kim, Seoyoung C.
    Schmidt, Bernhard M. W.
    Liu, Jun
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 55 - 55
  • [46] African American patients with gout: efficacy and safety of febuxostat vs allopurinol
    Wells, Alvin F.
    MacDonald, Patricia A.
    Chefo, Solomon
    Jackson, Robert L.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [47] Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
    Guan, Xudong
    Zhang, Shengzhao
    Liu, Jiayan
    Wu, Fengbo
    Zhou, Lingyan
    Liu, Ying
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
    Kang, Eun Ha
    Choi, Hyon K.
    Shin, Anna
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kim, Seoyoung C.
    RHEUMATOLOGY, 2019, 58 (12) : 2122 - 2129
  • [49] Comparison between Allopurinol and Febuxostat in management of gout patients - a prospective study
    Singal, K. K.
    Goyal, S.
    Gupta, P.
    Aggawal, B. K.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2011, 10 (04): : 257 - 259
  • [50] EFECTIVENESS OF FEBUXOSTAT IN PATIENTS WITH GOUT REFRACTORY OR INTOLERANT TO ALLOPURINOL IN CLINICAL PRACTICE
    Munoz Gomez, M. D. M.
    Pavo Blanco, M.
    Blanquez Martinez, D.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S316 - S317
12345